These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29105289)

  • 1. Predictors of care for patients with cancer of unknown primary site in three Australian hospitals.
    Tan SYS; O'Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e512-e520. PubMed ID: 29105289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP).
    Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM
    PLoS One; 2020; 15(3):e0230373. PubMed ID: 32191753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs clients.
    Vajdic CM; Schaffer AL; Dobbins TA; Ward RL; Er CC; Pearson SA
    Cancer Epidemiol; 2015 Aug; 39(4):585-92. PubMed ID: 26088263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients.
    Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM
    Cancer Epidemiol; 2015 Aug; 39(4):578-84. PubMed ID: 26100364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care.
    Creak A
    Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e87-e92. PubMed ID: 31635979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP).
    Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA
    Cancer Epidemiol; 2019 Jun; 60():156-161. PubMed ID: 31015097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
    Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
    Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
    Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP).
    Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA
    Cancer Epidemiol; 2019 Aug; 61():1-7. PubMed ID: 31082704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival.
    Dumbrava MI; Burmeister EA; Wyld D; Goldstein D; O'Connell DL; Beesley VL; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Waterhouse MA; Neale RE
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):326-336. PubMed ID: 29573158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in out-of-hospital death among palliative care inpatients across public hospitals in New South Wales, Australia.
    Assareh H; Stubbs JM; Trinh LTT; Muruganantham P; Achat HM
    Intern Med J; 2019 Apr; 49(4):467-474. PubMed ID: 30043405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of carcinoma of unknown primary in the head and neck.
    Issing WJ; Taleban B; Tauber S
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hospital-based services used by adults during the last year of life in New South Wales, Australia: a population-based retrospective cohort study.
    Goldsbury DE; O'Connell DL; Girgis A; Wilkinson A; Phillips JL; Davidson PM; Ingham JM
    BMC Health Serv Res; 2015 Dec; 15():537. PubMed ID: 26637373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
    Schapira DV; Jarrett AR
    Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative care and psychosocial care in metastatic non-small cell lung cancer: factors affecting utilisation of services and impact on patient survival.
    Duggan KJ; Wiltshire J; Strutt R; Boxer MM; Berthelsen A; Descallar J; Vinod SK
    Support Care Cancer; 2019 Mar; 27(3):911-919. PubMed ID: 30066201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a metastatic malignancy of unknown primary origin service led by a palliative physician.
    Brooks D; Hughes P; Farrington C; Bath PA; McGregor M; Ahmed W; Noble B
    Hosp Pract (1995); 2018 Feb; 46(1):37-42. PubMed ID: 29285946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.